US health regulators are looking at authorising a potential fourth dose of a Covid-19 vaccine in the fall, the Wall Street Journal reports, citing sources familiar with the matter.
The Food and Drug Administration has been reviewing data to authorise a second booster dose of the messenger RNA vaccines from Pfizer Inc and partner BioNTech SE and vaccines from Moderna Inc, the report adds.
